tert-Butyl 4-(4-chlorobenzylidene)piperidine-1-carboxylate

Catalog No. :
ACETVO524
CAS No. :
251107-35-4
Molecular Formula :
C17H22ClNO2
Molecular Weight :
307.82

IUPAC Name:tert-butyl 4-(4-chlorobenzylidene)piperidine-1-carboxylate

tert-Butyl 4-(4-chlorobenzylidene)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$112.00Login to see priceIn stockInquiry
250mg95%$190.00Login to see priceIn stockInquiry
1g95%$511.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(4-chlorobenzylidene)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(4-chlorobenzylidene)piperidine-1-carboxylate
MDL No.MFCD24465858
Molecular FormulaC17H22ClNO2
Molecular Weight307.82
SMILESO=C(N1CC/C(CC1)=C/C2=CC=C(Cl)C=C2)OC(C)(C)C
InChI KeyFEXIDQDEGTVERB-UHFFFAOYSA-N
Synonymtert-butyl 4-(4-chlorobenzylidene)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-[(4-chlorophenyl)methylene]-, 1,1-dimethylethyl ester
CAS No.251107-35-4
PubChem CID22893850

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACETVO524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOWFG409 route compound structure diagram
    ACOWFG40939225-17-7 In Stock
  4. Then
  5. ACETVO524 route product structure diagram
    ACETVO524251107-35-4 In Stock
Inquiry

2. ACETVO524 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACETVO524 route product structure diagram
    ACETVO524251107-35-4 In Stock
Inquiry

Comments (0)